Novare Capital Management’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9M | Buy |
105,807
+1,458
| +1% | +$165K | 0.86% | 44 |
|
|
2025
Q4 | $13.1M | Buy |
104,349
+1,294
| +1% | +$165K | 0.98% | 33 |
|
|
2025
Q3 | $13.8M | Sell |
103,055
-1,593
| -2% | -$209K | 1.05% | 27 |
|
|
2025
Q2 | $14.2M | Buy |
104,648
+629
| +0.6% | +$82.9K | 1.16% | 23 |
|
|
2025
Q1 | $13.8M | Sell |
104,019
-2,055
| -2% | -$262K | 1.21% | 24 |
|
|
2024
Q4 | $12M | Sell |
106,074
-475
| -0.4% | -$54.9K | 1.01% | 34 |
|
|
2024
Q3 | $12.1M | Buy |
106,549
+1,434
| +1% | +$157K | 1.03% | 35 |
|
|
2024
Q2 | $10.9M | Sell |
105,115
-1,016
| -1% | -$108K | 0.98% | 38 |
|
|
2024
Q1 | $12.1M | Buy |
106,131
+2,363
| +2% | +$271K | 1.09% | 29 |
|
|
2023
Q4 | $11.4M | Buy |
103,768
+6,073
| +6% | +$607K | 1.16% | 29 |
|
|
2023
Q3 | $9.46M | Buy |
97,695
+2,034
| +2% | +$214K | 1.07% | 33 |
|
|
2023
Q2 | $10.4M | Buy |
95,661
+879
| +0.9% | +$93.7K | 1.12% | 28 |
|
|
2023
Q1 | $9.6M | Sell |
94,782
-359
| -0.4% | -$37.9K | 1.09% | 31 |
|
|
2022
Q4 | $10.4M | Buy |
95,141
+54
| +0.1% | +$5.59K | 1.23% | 25 |
|
|
2022
Q3 | $9.2M | Buy |
95,087
+1,657
| +2% | +$177K | 1.18% | 24 |
|
|
2022
Q2 | $10.2M | Buy |
93,430
+883
| +1% | +$100K | 1.25% | 24 |
|
|
2022
Q1 | $11M | Sell |
92,547
-2,441
| -3% | -$303K | 1.17% | 26 |
|
|
2021
Q4 | $13.4M | Buy |
94,988
+819
| +0.9% | +$105K | 1.36% | 23 |
|
|
2021
Q3 | $11.1M | Buy |
94,169
+305
| +0.3% | +$37.5K | 1.23% | 27 |
|
|
2021
Q2 | $10.9M | Buy |
93,864
+2,516
| +3% | +$293K | 1.22% | 25 |
|
|
2021
Q1 | $10.9M | Buy |
91,348
+1,922
| +2% | +$228K | 1.32% | 24 |
|
|
2020
Q4 | $9.79M | Sell |
89,426
-3,282
| -4% | -$357K | 1.28% | 23 |
|
|
2020
Q3 | $10.1M | Sell |
92,708
-2,003
| -2% | -$203K | 1.42% | 19 |
|
|
2020
Q2 | $8.66M | Sell |
94,711
-4,205
| -4% | -$380K | 1.3% | 23 |
|
|
2020
Q1 | $7.8M | Sell |
98,916
-1,040
| -1% | -$86.8K | 1.37% | 19 |
|
|
2019
Q4 | $8.68M | Buy |
99,956
+1,610
| +2% | +$135K | 1.21% | 25 |
|
|
2019
Q3 | $8.23M | Sell |
98,346
-3,103
| -3% | -$264K | 1.22% | 25 |
|
|
2019
Q2 | $8.53M | Sell |
101,449
-2,212
| -2% | -$174K | 1.3% | 22 |
|
|
2019
Q1 | $8.29M | Sell |
103,661
-4,010
| -4% | -$298K | 1.3% | 24 |
|
|
2018
Q4 | $7.79M | Sell |
107,671
-1,400
| -1% | -$98.4K | 1.42% | 19 |
|
|
2018
Q3 | $8M | Buy |
109,071
+45
| +0% | +$2.96K | 1.28% | 28 |
|
|
2018
Q2 | $6.65M | Buy |
109,026
+1,100
| +1% | +$66.7K | 1.13% | 34 |
|
|
2018
Q1 | $6.47M | Buy |
107,926
+1,631
| +2% | +$98.3K | 1.13% | 30 |
|
|
2017
Q4 | $6.07M | Buy |
106,295
+4,533
| +4% | +$251K | 1.03% | 38 |
|
|
2017
Q3 | $5.43M | Buy |
101,762
+5,243
| +5% | +$263K | 0.96% | 42 |
|
|
2017
Q2 | $4.69M | Buy |
96,519
+26,865
| +39% | +$1.22M | 1.06% | 48 |
|
|
2017
Q1 | $3.09M | Buy |
+69,654
| New | +$3.01M | 0.72% | 63 |
|
Other funds holding ABT
VCM
VPM
Novare Capital Management's ABT Position: Q1 2026 in Review
Novare Capital Management increased its Abbott (ABT) stake by 1.4% in Q1 2026, buying an estimated $165K and bringing the position to 105,807 shares worth $10.9M. The position accounts for 0.86% of the portfolio, ranked #44.
Novare Capital Management first reported a position in ABT in Q1 2017 and has held it in 37 quarters since. The position peaked at $14.2M in Q2 2025. 3,088 funds tracked by Wall St. Rank hold ABT as of Q1 2026.
- Novare Capital Management held 105,807 shares of Abbott worth $10.9M as of Q1 2026.
- Novare Capital Management bought 1,458 Abbott shares in Q1 2026, an estimated $165K.
- Abbott made up 0.86% of Novare Capital Management's portfolio in Q1 2026, its #44 holding.
- Novare Capital Management first reported a position in Abbott in Q1 2017 and has held it in 37 quarters since.
- Novare Capital Management's Abbott position peaked at $14.2M in Q2 2025.
- 3,088 funds tracked by Wall St. Rank held Abbott as of Q1 2026.
Based on Novare Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.